Ignite Creation Date:
2024-05-06 @ 2:30 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04334993
Status:
RECRUITING
Last Update Posted:
2021-05-07
First Post:
2020-03-31
Brief Title:
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Sponsor:
Israeli Medical Association
Organization:
Israeli Medical Association
Organization Data
Organization:
Israeli Medical Association
Class:
OTHER
Study ID:
AYA001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Israeli Medical Association
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None